All In MedTech

FDA Clearance Tracker · P190006-S078

Axonics Sacral Neuromodulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 2, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 2, 2024

Approved

Time to decision

190 days

Received Jan 25, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190006-S078
Device name
Axonics Sacral Neuromodulation System
Applicant location
Marlborough, MA
Received
Jan 25, 2024
Decided
Aug 2, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P190006

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

Approval for labeling updates on compatible medical procedures for the rechargeable (1101, 5101) and non-rechargeable (4101) models of the Axonics Sacral Neuromodulation System

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.